These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34766004)

  • 21. A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp).
    Ribaudo G; Ongaro A; Oselladore E; Zagotto G; Memo M; Gianoncelli A
    J Biomol Struct Dyn; 2022 Feb; 40(3):1101-1108. PubMed ID: 32948103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating the potential of natural compounds as novel inhibitors of SARS-CoV-2 RdRP using computational approaches.
    Bagabir SA
    Biotechnol Genet Eng Rev; 2023 Mar; ():1-21. PubMed ID: 36994810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study.
    Gogoi M; Borkotoky M; Borchetia S; Chowdhury P; Mahanta S; Barooah AK
    J Biomol Struct Dyn; 2022 Sep; 40(15):7143-7166. PubMed ID: 33715595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study.
    Elfiky AA
    Life Sci; 2020 Jul; 253():117592. PubMed ID: 32222463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RETRACTED ARTICLE: Discovery of (
    Rabie AM
    Chem Zvesti; 2021; 75(9):4669-4685. PubMed ID: 34025012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico.
    Elfiky AA; Azzam EB; Shafaa MW
    Mol Divers; 2022 Feb; 26(1):171-181. PubMed ID: 33389441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
    Khan A; Khan M; Saleem S; Babar Z; Ali A; Khan AA; Sardar Z; Hamayun F; Ali SS; Wei DQ
    Interdiscip Sci; 2020 Sep; 12(3):335-348. PubMed ID: 32617855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of SARS-CoV-2 RNA dependent RNA polymerase inhibitors using pharmacophore modelling, molecular docking and molecular dynamics simulation approaches.
    Pundir H; Joshi T; Pant M; Bhat S; Pandey J; Chandra S; Tamta S
    J Biomol Struct Dyn; 2022; 40(24):13366-13377. PubMed ID: 34637693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an
    Elfiky AA
    J Biomol Struct Dyn; 2021 Jun; 39(9):3204-3212. PubMed ID: 32338164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19.
    Vicenti I; Zazzi M; Saladini F
    Expert Opin Ther Pat; 2021 Apr; 31(4):325-337. PubMed ID: 33475441
    [No Abstract]   [Full Text] [Related]  

  • 32. Repurposing FDA-approved phytomedicines, natural products, antivirals and cell protectives against SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase.
    Kandeel M; Kitade Y; Almubarak A
    PeerJ; 2020; 8():e10480. PubMed ID: 33335812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp).
    Bibi S; Hasan MM; Wang YB; Papadakos SP; Yu H
    Curr Med Chem; 2022; 29(1):152-162. PubMed ID: 34420502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Novel Thioether-Amide or Guanidine-Linker Class of SARS-CoV-2 Virus RNA-Dependent RNA Polymerase Inhibitors Identified by High-Throughput Virtual Screening Coupled to Free-Energy Calculations.
    Jukič M; Janežič D; Bren U
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity.
    Tsuji M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs.
    Hosseini M; Chen W; Xiao D; Wang C
    Precis Clin Med; 2021 Mar; 4(1):1-16. PubMed ID: 33842834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin.
    Kwofie SK; Broni E; Asiedu SO; Kwarko GB; Dankwa B; Enninful KS; Tiburu EK; Wilson MD
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33466743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (M
    Piplani S; Singh P; Petrovsky N; Winkler DA
    Front Mol Biosci; 2022; 9():781039. PubMed ID: 35359601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug Discovery.
    Zhao Z; Bourne PE
    J Proteome Res; 2020 Nov; 19(11):4698-4705. PubMed ID: 32946692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics.
    Piplani S; Singh P; Petrovsky N; Winkler DA
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.